7 results
There will be three formal interim analyses during the study. Interim Analysis 1 will occur at the end of Phase II when approximately 162 PFS events (defined as disease progression or death due to any cause, whichever occurs first) have been…
Primary objective: * To assess the treatment effect on progression-free survival in patients who receive AUY922 on a once-weekly schedule versus patients who receive docetaxel or irinotecanSecondary Objectives* To estimate the overall survival…
Goal of this study is to assess the feasibility of a biodegradable polyurethane foam for closing of oroantral communications with a few modifications compared to the first pilot study. The assessment will take place in a small number of patients. On…
Goal of this study is to asses the feasibility of polyurethane foam as a local hemostatic agents in sockets after dental extraction. The assessment will take place in a small number of patients. After the pilot study, a large study will be…
Goal of this study is to assess the feasibility of a biodegradable polyurethane foam for closing of oroantral communications. The assessment will take place in a small number of patients. On the long term, the objective is the clinical appliance of…
Goal of this study is to assess the treatment of OACs with biodegradable polyurethane foam, as carried out in the pilot studies, in a large number of patients.
The aim of the study is to evaluate the effect of MCP in acutely decompensated HF with the primary objective being its effect on the cumulative amount of diuretics needed and the length of the hospital stay due to decompenstaed heart failure .…